4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-20-015362
Chief Financial Officer acquired 66,875 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Koppikar Utpal Chief Financial Officer | 2020-03-01 | Grant or award | +66,875 | 139,157 | D | ||
| Derivatives | |||||||
| Koppikar Utpal Chief Financial Officer | 2020-03-01 | Grant or award · Employee Stock Option (Right to Buy) | +73,750 | 73,750 | D | ||
Loading xslF345X03/doc4.xml…